• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Myriad Genetics (MYGN)

Common Shares
Sell: $6.78|Buy: $7.70|Change: 0.09 (-1.23%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Address

320 Wakara Way
Salt Lake City
UT
USA
84108

Telephone

+1 801 5841143

Website

https://www.myriad.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Myriad Genetics Inc Third Quarter Earnings Conference Call for 20262026-11-03T16:30:00
Myriad Genetics Inc Third Quarter Earnings Results for 20262026-11-03T00:00:00
Myriad Genetics Inc Second Quarter Earnings Conference Call for 20262026-08-05T16:30:00
Myriad Genetics Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
Myriad Genetics Inc Annual General Meeting for 20262026-06-05T08:00:00
Myriad Genetics Inc First Quarter Earnings Conference Call for 20262026-05-06T16:30:00
Myriad Genetics Inc First Quarter Earnings Results for 20262026-05-06T00:00:00
Myriad Genetics Inc Annual Report for 20252026-02-27T00:00:00
Myriad Genetics Inc Fourth Quarter Earnings Conference Call for 20252026-02-24T16:30:00
Myriad Genetics Inc Fourth Quarter Earnings Results for 20252026-02-24T00:00:00
The 37th Annual Piper Sandler Healthcare Conference2025-12-02T12:00:00

Previous key dates

NameKey Date
The 37th Annual Piper Sandler Healthcare Conference2025-12-02T12:00:00
The 7th Annual Wolfe Research Healthcare Conference2025-11-18T13:20:00
Myriad Genetics Inc Third Quarter Earnings Conference Call for 20252025-11-03T16:30:00
Myriad Genetics Inc Third Quarter Earnings Results for 20252025-11-03T00:00:00
The Morgan Stanley Annual Global Healthcare Conference2025-09-10T07:45:00
2025 Wells Fargo Healthcare Conference2025-09-04T03:45:00
Myriad Genetics Inc Second Quarter Earnings Conference Call for 20252025-08-05T16:30:00
Myriad Genetics Inc Second Quarter Earnings Results for 20252025-08-05T00:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-11T14:00:00
Myriad Genetics Inc Annual General Meeting for 20252025-06-05T08:00:00
The BofA Securities 2025 Health Care Conference2025-05-14T15:00:00
Myriad Genetics Inc First Quarter Earnings Conference Call for 20252025-05-06T16:30:00
Myriad Genetics Inc First Quarter Earnings Results for 20252025-05-06T00:00:00
The Leerink Global Healthcare Conference2025-03-10T14:20:00
The Raymond James 46th Annual Institutional Investors Conference2025-03-04T16:00:00
The TD Cowen 45th Annual Health Care Conference2025-03-04T09:50:00
Myriad Genetics Inc Annual Report for 20242025-02-28T00:00:00
Myriad Genetics Inc Fourth Quarter Earnings Conference Call for 20242025-02-24T16:30:00
Myriad Genetics Inc Fourth Quarter Earnings Result for 20242025-02-24T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-15T15:45:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.